MoneyWorks4Me

The sales figure stood at Rs. 1025.42 millions for the March 2022 quarter. The mentioned figure indicates a growth of about 28.88% as compared to Rs. 795.65 millions during the year-ago period.The Net Profit of the company registered a slight decline of -12.31% to Rs. 110.24  millions from Rs. 125.71 millions.Operating profit for the quarter ended March 2022 rose to 193.26 millions as compared to 178.17 millions of corresponding quarter ended March 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1025.42 795.65 28.88 4720.79 4229.08 11.63 4720.79 4229.08 11.63
Other Income 18.91 23.86 -20.75 99.98 57.43 74.09 99.98 57.43 74.09
PBIDT 193.26 178.17 8.47 1054.68 927.83 13.67 1054.68 927.83 13.67
Interest 5.66 5.68 -0.35 14.51 15.52 -6.51 14.51 15.52 -6.51
PBDT 187.60 172.49 8.76 1040.17 912.31 14.01 1040.17 912.31 14.01
Depreciation 19.98 18.92 5.60 80.88 75.60 6.98 80.88 75.60 6.98
PBT 167.62 153.57 9.15 959.29 836.71 14.65 959.29 836.71 14.65
TAX 57.38 27.86 105.96 265.74 214.21 24.06 265.74 214.21 24.06
Deferred Tax 5.64 -3.57 -257.98 7.20 2.47 191.50 7.20 2.47 191.50
PAT 110.24 125.71 -12.31 693.55 622.50 11.41 693.55 622.50 11.41
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 18.85 22.39 -15.84 22.34 21.94 1.83 22.34 21.94 1.83
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..